Overview
A remote opportunity is available for a Technology Transactions/Commercial Counsel to support a large life sciences technology company on an acquisition-related initiative. The focus is on structured asset acquisitions involving Clinical Outcome Assessments (COAs), related documentation, validation materials, and limited enabling software. This role involves handling transaction aspects, including commercial and technology agreements, and collaborating with legal, clinical, technical, and business teams.
Responsibilities
- Support structured asset acquisition processes primarily involving Clinical Outcome Assessments (COAs), related documentation, validation materials, and limited enabling software.
- Draft, review, and negotiate commercial and technology agreements related to acquisitions.
- Collaborate closely with legal, clinical, technical, and business teams to support acquisition activities.
- Manage transaction-related work for acquisitions.
Requirements
- 5-10 years of relevant legal practice experience.
- Experience with structured asset acquisitions, commercial agreements, and technology transactions.
- Familiarity with transactional work involving intangible assets.
- Ability to work effectively with cross-functional teams including legal, clinical, technical, and business stakeholders.
- Juris Doctor (JD) degree and licensed to practice law in an applicable jurisdiction.
Preferred Qualifications
- Experience with technology, SaaS, or intellectual property-related transactions.
- Proven ability to work effectively in a cross-functional environment.
Compensation & Benefits
- Estimated total compensation range: $104,500 to $325,000 per year for full-time attorney roles.
- Compensation is based on factors such as experience, skills, certifications, location, and business needs.
- Eligibility for benefits including health, dental, and vision insurance; paid holidays and paid time off; flexible work arrangements; and professional development opportunities.
Location
This role requires collaboration across multiple disciplines and offers the opportunity to engage in complex acquisition transactions within the life sciences technology sector.